The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant

Vaccine

Volumn 26, Issue 6, 2008, Pages 786-796

  Liu, Xiuping ^a   Wetzler, Lee M ^a   Massari, Paola ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

Adjuvant; Commensal bacteria; Immune stimulation; Porin

Indexed keywords

ALUMINUM POTASSIUM SULFATE; BACTERIAL PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; OVALBUMIN; PROTEIN NLAC PORB; PROTEIN NME PORB; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE ACTIVATION; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; DRUG PURIFICATION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; MOUSE; NEISSERIA LACTAMICA; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; B-LYMPHOCYTES; CELLS, CULTURED; IMMUNIZATION; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; INTERFERON TYPE II; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; NEISSERIA LACTAMICA; OVALBUMIN; PORINS; SPLEEN; TH1 CELLS; TH2 CELLS;

EID: 38349075841     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.11.080     Document Type: Article

References (75)

1. Chedid L. Adjuvants of immunity. Ann Inst Pasteur Immunol 136D (1985) 283-291
2. Gupta R.K., Relyveld E.H., Lindblad E.B., Bizzini B., Ben Efraim S., and Gupta C.K. Adjuvants-a balance between toxicity and adjuvanticity. Vaccine 11 (1993) 293-306
3. Lindblad E.B. Aluminium compounds for use in vaccines. Immunol Cell Biol 82 (2004) 497-505
4. Freund J. The mode of action of immunologic adjuvants. Bibl Tuberc (1956) 130-148
5. Hilleman M.R. Critical appraisal of emulsified oil adjuvants applied to viral vaccines. Prog Med Virol 8 (1966) 131-182
6. Ott G., Barchfeld G.L., Chernoff D., Radhakrishnan R., van Hoogevest P., and Van Nest G. MF59. Design and evaluation of a safe and potent adjuvant for human vaccines. Pharm Biotechnol 6 (1995) 277-296
7. Asa P.B., Wilson R.B., and Garry R.F. Antibodies to squalene in recipients of anthrax vaccine. Exp Mol Pathol 73 (2002) 19-27
8. de Vries P., van Binnendijk R.S., van der M.P., van Wezel A.L., Voorma H.O., Sundquist B., et al. Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice. J Gen Virol 69 Pt 3 (1988) 549-559
9. Lovgren K., and Morein B. The ISCOM: an antigen delivery system with built-in adjuvant. Mol Immunol 28 (1991) 285-286
10. Allison A.C., and Gregoriadis G. Liposomes as immunological adjuvants. Recent Results Cancer Res (1976) 58-64
11. Alving C.R. Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants. Immunobiology 187 (1993) 430-446
12. Balboa J.A., Cuello M., Cabrera O., del Campo J., Lastre M., Gil D., et al. Adjuvant properties of lipopolysaccharide from Neisseria meningitidis serogroup B detoxified and conjugated with tetanus toxoid. Vaccine 24 Suppl. 2 (2006) S2-S4
13. Klinman D.M. Adjuvant activity of CpG oligodeoxynucleotides. Int Rev Immunol 25 (2006) 135-154
14. Ryan M., McCarthy L., Rappuoli R., Mahon B.P., and Mills K.H. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28. Int Immunol 10 (1998) 651-662
15. Bizzini B., Carlotti M., and Fattal-German M. Induction of various cytokines in mice and activation of the complement system in rats as a part of the mechanism of action of the Corynebacterium granulosum-derived P40 immunomodulator. FEMS Microbiol Immunol 5 (1992) 171-180
16. Thoelen S., Van Damme P., Mathei C., Leroux-Roels G., Desombere I., Safary A., et al. Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system. Vaccine 16 (1998) 708-714
17. McLaughlin C.A., Schwartzman S.M., Horner B.L., Jones G.H., Moffatt J.G., Nestor Jr. J.J., et al. Regression of tumors in guinea pigs after treatment with synthetic muramyl dipeptides and trehalose dimycolate. Science 208 (1980) 415-416
18. Rappuoli R., Pizza M., Douce G., and Dougan G. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. Immunol Today 20 (1999) 493-500
19. Takada H., Ogawa T., Yoshimura F., Otsuka K., Kokeguchi S., Kato K., et al. Immunobiological activities of a porin fraction isolated from Fusobacterium nucleatum ATCC 10953. Infect Immun 56 (1988) 855-863
20. Ray A., Chatterjee N.S., Bhattacharya S.K., and Biswas T. Porin of Shigella dysenteriae enhances mRNA levels for Toll-like receptor 2 and MyD88, up-regulates CD80 of murine macrophage, and induces the release of interleukin-12. FEMS Immunol Med Microbiol 39 (2003) 213-219
21. Biswas A., Banerjee P., Mukherjee G., and Biswas T. Porin of Shigella dysenteriae activates mouse peritoneal macrophage through Toll-like receptors 2 and 6 to induce polarized type I response. Mol Immunol 44 (2007) 812-820
22. Alurkar V., and Kamat R. Immunomodulatory properties of porins of some members of the family Enterobacteriaceae. Infect Immun 65 (1997) 2382-2388
23. Secundino I., Lopez-Macias C., Cervantes-Barragan L., Gil-Cruz C., Rios-Sarabia N., Pastelin-Palacios R., et al. Salmonella porins induce a sustained, lifelong specific bactericidal antibody memory response. Immunology 117 (2006) 59-70
24. Wetzler L.M., Blake M.S., Barry K., and Gotschlich E.C. Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes and blebs isolated from rmp deletion mutants. J Infect Dis 166 (1992) 551-555
25. Wetzler L.M. Immunopotentiating ability of neisserial major outer membrane proteins. Use as an adjuvant for poorly immunogenic substances and potential use in vaccines. Ann NY Acad Sci 730 (1994) 367-370
26. Wetzler L.M., Ho Y., and Reiser H. Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J Exp Med 183 (1996) 1151-1159
27. Fusco P.C., Michon F., Laude-Sharp M., Minetti C.A., Huang C.H., Heron I., et al. Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine. Vaccine 16 (1998) 1842-1849
28. Christodoulides M., Brooks J.L., Rattue E., and Heckels J.E. Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci. Microbiology 144 Pt 11 (1998) 3027-3037
29. Peeters C.C., Claassen I.J., Schuller M., Kersten G.F., van der Voort E.M., and Poolman J.T. Immunogenicity of various presentation forms of PorA outer membrane protein of Neisseria meningitidis in mice. Vaccine 17 (1999) 2702-2712
30. Mackinnon F.G., Ho Y., Blake M.S., Michon F., Chandraker A., Sayegh M.H., et al. The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porin. J Infect Dis 180 (1999) 755-761
31. Massari P., Henneke P., Ho Y., Latz E., Golenbock D.T., and Wetzler L.M. Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent. J Immunol 168 (2002) 1533-1537
32. Singleton T.E., Massari P., and Wetzler L.M. Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent. J Immunol 174 (2005) 3545-3550
33. Snapper C.M., Rojas F.R., Kerry M.M., Mind J.J., and Wetzler L.M. Neisserial porins may provide critical second signals to polysaccharide-activated murine B cells for induction of immunoglobulin secretion. Infect Immun 65 (1997) 3203-3208
34. Poolman J.T. Meningococcal vaccines. J Med Microbiol 26 (1988) 170-172
35. Zollinger W.D. New and improved vaccines against meningococcal disease. In: Woodrow G.C., and Levine M.M. (Eds). New generation vaccines (1990), Marcel Decker, Inc., New York 325-348
36. Mosman T.R., and Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7 (1989) 145-173
37. Chow J.C., Young D.W., Golenbock D.T., Christ I.J., and Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274 (1999) 10689-10692
38. Takeda K., Takeuchi O., and Akira S. Recognition of lipopeptides by Toll-like receptors. J Endotoxin Res 8 (2002) 459-463
39. Romagnani S. Development of Th 1- or Th 2-dominated immune responses: what about the polarizing signals?. Int J Clin Lab Res 26 (1996) 83-98
40. Zhang G., and Ghosh S. Toll-like receptor-mediated NF-kappa activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 107 (2001) 13-19
41. Krutzik S.R., Sieling P.A., and Modlin L. The role of Toll-like receptors in host defense against microbial infection. Curr Opin Immunol 13 (2001) 104-108
42. Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R., et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410 (2001) 1099-1103
43. Rumbo M., Nempont C., Kraehenbuhl J.P., and Sirard J.C. Mucosal interplay among commensal and pathogenic bacteria: lessons from flagellin and Toll-like receptor 5. FEMS Lett 580 (2006) 2976-2984
44. Bambou J.C., Giraud A., Menard S., Begue B., Rakotobe S., Heyman M., et al. In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain. J Biol Chem 279 (2004) 42984-42992
45. Akira S. Toll-like receptors and innate immunity. Adv Immunol 78 (2001) 1-56
46. Kaisho T., and Akira S. Toll-like receptors as adjuvant receptors. Biochem Biophys Acta 1589 (2002) 1-13
47. Pulendran B. Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol Rev 199 (2004) 227-250
48. Mlckova P., Cechova D., Chalupna P., Novotna O., and Prokesova L. Enhanced systemic and mucosal antibody responses to a model protein antigen after intranasal and intra tracheal immunization using Bacillus firmus as an adjuvant. Immunol Lett 77 (2001) 39-45
49. Barnes A.G., Cerovic V., Hobson P.S., and Klavinskis L.S. Bacillus subtilis spores: a novel micro particle adjuvant which can instruct a balanced Th1 and Th2 immune response to specific antigen. Eur J Immunol 37 (2007) 1538-1547
50. Smits H.H., van Beelen A.J., Hessle C., Westland R., de Jong E., Soeteman E., et al. Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development. Eur J Immunol 34 (2004) 1371-1380
51. Derrick J.P., Urwin R., Suker J., Feavers I.M., and Maiden M.C. Structural and evolutionary inference from molecular variation in Neisseria porins. Infect Immun 67 (1999) 2406-2413
52. Gold R., Goldschneider I., Lepow M.L., Draper G.F., and Randolph M. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J Infect Dis 137 (1978) 112-121
53. Olsen S.F., Djurhuus B., Rasmussen K., Joensen H.D., Larsen S.O., Zoffman H., et al. Pharyngeal carriage of Neisseria meningitidis and Neisseria lactamica in households with infants within areas with high and low incidences of meningococcal disease. Epidemiol Infect 106 (1991) 445-457
54. Oliver K.J., Reddin K.M., Bracegirdle P., Hudson I.J., Borrow R., Feavers I.M., et al. Neisseria lactamica protects against experimental meningococcal infection. Infect Immun 70 (2002) 3621-3626
55. Guttormsen H.K., Bjerknes R., Halstensen A., Naess A., Hoiby E.A., and Solberg C.O. Cross-reacting serum opsonins to meningococci after vaccination. J Infect Dis 167 (1993) 1314-1319
56. Massari P., King C.A., Macleod H., and Wetzler L.M. Improved purification of native meningococcal porin PorB and studies on its structure/function. Protein Exp Purify 44 2 (2005) 136-146
57. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
58. Tsai C.M., and Frasch C.E. A sensitive silver stain for detecting Lipopolysaccharide in polyacrylamide gels. Anal Biochem 119 (1982) 115-119
59. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
60. Yang Z., Chen A., Sun H., Ye Y., and Fang W. Ginsenoside Rd elicits Th1 and Th2 immune responses to ovalbumin in mice. Vaccine 25 (2007) 161-169
61. Troncoso G., Sanchez S., Criado M.T., and Ferreiros C.M. Analysis of Neisseria lactamica antigens putatively implicated in acquisition of natural immunity to Neisseria meningitidis. FEMS Immunol Med Microbiol 34 (2002) 9-15
62. Vaughan T.E., Skipp P.J., O'connor C.D., Hudson M.J., Vipond R., Elmore M.J., et al. Proteomic analysis of Neisseria lactamica and Neisseria meningitidis outer membrane vesicle vaccine antigens. Vaccine 24 25 (2006) 5277-5293
63. Sanchez S., Arenas J., Abel A., Criado M.T., and Ferreiros C.M. Analysis of outer membrane protein complexes and heat-modifiable proteins in Neisseria strains using two-dimensional diagonal electrophoresis. J Proteome Res 4 (2005) 91-95
64. Germann T., Rude E., and Schmitt E. The influence of IL12 on the development of Th1 and Th2 cells and its adjuvant effect for humoral immune responses. Res Immunol 146 (1995) 481-486
65. Massari P., Visintin A., Gunawardana J., Halmen K.A., King C.A., Golenbock D.T., et al. Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling. J Immunol 176 (2006) 2373-2380
66. Minetti C.A., Tai J.T., Blake M.S., Pullen J.K., Liang S.M., and Remeta D.P. Structural and functional characterization of a recombinant PorB class 2 protein from Neisseria meningitides. Conformational stability and porin activity. J Biol Chem 272 (1997) 10710-10720
67. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologous of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
68. Dillon S., Agrawal A., Van Dyke T., Landreth G., McCauley L., Koh A., et al. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-FBS in dendritic cells. J Immunol 172 (2004) 4733-4743
69. Imanishi T., Hara H., Suzuki S., Suzuki N., Akira S., and Saito T. Cutting Edge: TLR2 directly triggers Th1 effector functions. J Immunol 178 (2007) 6715-6719
70. O'Neill L.A., and Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signaling. Nat Rev Immunol 7 (2007) 353-364
71. Fischer H., Yamamoto M., Akira S., Beutler B., and Svanborg C. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. Eur J Immunol 36 (2006) 267-277
72. Balmer P., Borrow R., and Miller E. Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol 51 (2002) 717-722
73. Rudel T., Schmid A., Benz R., Kolb H.A., Lang F., and Meyer T.F. Modulation of Neisseria porin (PorB) by cytosolic ATP/GTP of target cells: parallels between pathogen accommodation and mitochondrial endosymbiosis. Cell 85 (1996) 391-402
74. Qi H.L., Tai J.Y., and Blake M.S. Expression of large amounts of neisserial porin proteins in Escherichia coli and refolding of the proteins into native trimers. Infect Immun 62 6 (1994) 2432-2439
75. Wright J.C., Williams J.N., Christodoulides M., and Heckels J.E. Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis. Infect Immun 70 8 (2002) 4028-4034